Skip to main content
What We Do: A Letter To Investors From Cathie Wood Read Now

Looking For Our European Funds?

Click Here
About How To Invest
ARK Invest logo
You Are Entering ark-funds.com

Please read this page before proceeding, as it explains certain restrictions imposed by law on the distribution of this information and the countries in which the funds are authorized for sale. By proceeding, you are confirming you understand that ARK Investment Management LLC or its affiliates (collectively, “ARK”), makes no representation that the content of the website is appropriate for use in all locations, or that the transactions, securities, products, instruments or services discussed at this website are available or appropriate for sale or use in all jurisdictions or countries, or by all investors or counterparties.


This section of the website is operated by ARK, and is only directed at U.S. investors or those otherwise authorized to conduct investment business in the U.S. Persons resident in territories other than the United States should not access this website.


It is your responsibility to be aware of and to observe all applicable laws and regulations of any relevant jurisdiction. Certain of the funds and advisory products and services referenced on this website may be managed or offered/provided by affiliates of ARK. Additionally, certain of the funds described in the following pages may be marketed in certain jurisdictions only. Any entity forwarding the material or information contained on this website, which is produced by ARK in the United States, to other parties takes full responsibility for ensuring compliance with applicable securities laws in connection with its distribution.


This website only includes information on those funds that are registered for sale in the United States.


By accessing this website, you are confirming that you agree to the Terms and Conditions of this website and that you are resident in the United States or those otherwise authorized to conduct investment business in the U.S.


The contents of this website have been prepared for informational purposes only without regard to the investment objectives, financial situation, or means of any particular person or entity, and ARK is not soliciting any action based upon them. No information included on this website is to be construed as investment advice or as a recommendation or a representation about the suitability or appropriateness of any fund; or an offer to buy or sell, or the solicitation of an offer to buy or sell, any security, financial product, or instrument; or to participate in any particular trading strategy. ARK recommends that you seek independent financial and tax advice before making any investment decisions. Investment in any of the funds described in this website should only be made on the basis of the terms and conditions of the most recent applicable offering documents (including any relevant supplements).


All material has been obtained from sources believed to be reliable, but its accuracy is not guaranteed. Some of the content on this website may contain certain statements that may be deemed forward-looking statements. Please note that any such statements are not guarantees of any future performance and actual results or developments may differ materially from those projected. From time to time, ARK may also make additional features available to users on this website on such terms and conditions as may be set forth in a modification to this Agreement or otherwise on the ARK website.


The ARK ETF Trust Thematic Actively Managed ETF’s are distributed by Foreside Fund Services, LLC (“Foreside“), which is not affiliated with ARK Investment Management LLC. Check the background of Foreside on FINRA’s BrokerCheck.


You should carefully consider the investment objective, risks, charges and expenses of a Fund before investing. A Fund’s prospectus and summary prospectus contain this and other important information about a Fund, which can be obtained by clicking the corresponding link or dialing the indicated phone number herein. Please read the appropriate prospectus carefully before investing.


GENERAL RISK FACTORS


You should be aware that past performance is not a reliable indicator of future performance. Please note that the price of units or shares and the income from them can fall as well as rise and you may not get back the amount originally invested. Income receivable may vary from the amount of income projected at the time of making the investment.


Exchange rate fluctuations may affect the value of an investment and any income derived from it.


If you exercise any right to redeem, you may not get back the amount initially invested if the unit or share price has fallen since you invested. Deductions for charges and expenses, particularly the initial charge (if any), are not made uniformly throughout the life of the investment, so if you redeem out of the investment during the early years, you may not get back the amount invested.


There can be no guarantee that the tax position or proposed tax position prevailing at the time of an investment will not change. Dividends and capital gains on securities issued in the relevant funds may be subject to withholding taxes imposed by the countries in which each particular fund invests.


The offering documents for the investment funds contain important information summarizing the relevant risk factors pertaining to the investment or relevant funds. Please note, however, that no summary of risk factors is exhaustive, and there may be other risks that could affect your investment. For your own benefit and protection you should read the most recent offering documents (including any relevant supplements) carefully before investing. If you do not understand any point please ask for further information.


The information provided on this website is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation, or which would subject any of the funds described herein, ARK (including its affiliates) or any of their products or services to any registration, licensing or other authorization requirement within such jurisdiction or country. Nothing on this website shall be considered a solicitation to buy or sell a security, product or service (including advisory service) to any person.


HYPERLINKS


ARK does not recommend or endorse and accepts no responsibility for the content of any website not operated by ARK which you may visit by following a link from this website. You acknowledge and agree that neither ARK nor any of its affiliates is responsible for the availability of such third-party websites or resources, does not endorse, approve, investigate or verify, and is not responsible or liable for any content, advertising, products, or other materials on or available from such websites or resources. You further agree that neither ARK nor any of its affiliates shall be responsible or liable, directly or indirectly, for any damage or loss caused or alleged to be caused by or in connection with use of or reliance on any such content, products or services available on such external websites or resources. These links are provided as a convenience and solely for informational purposes. ARK is not making any recommendation to invest in, purchase, or sell any securities or other products or services offered on the linked websites, nor has ARK sought to verify or confirm the information contained in the linked websites. Accordingly, ARK disclaims any responsibility for the linked websites.


No other website, without the prior written permission of ARK, is authorized to link to any part of this website.


COOKIES


ARK uses cookies for collecting user information from certain pages of this website. A cookie is a file that is stored on the hard disk of a computer by the web browser on a computer. It contains information sent by the website that a user has visited. A cookie identifies users and can store information about them and their use of a website. ARK uses cookies to keep track of user activity, which allows ARK to identify which areas of the website are more interesting to the users so that improvements can be made to this website.


ARK expressly reserves the right to monitor any use of this website.


I confirm that I have read and accept the Terms and Conditions of using this website and that I am based in the United States or those otherwise authorized to conduct investment business in the United States.

Q3 2020: Commentary From ARK’s CIO

September 30, 2020 | ETF

By ARK Invest

During the third quarter, broad-based equity indexes – as measured by the S&P 500 and MSCI World – continued to appreciate, hitting all-time highs. Much like other policymakers around the world, in an effort to prevent a relapse into recession, the Fed reinforced that it will err on the side of ease with an asymmetric response to inflation. Specifically, given the long period of time that inflation has hovered below its 2% target, the Fed will not react immediately to readings above 2%; yet, if inflation were to rise and then drop back below the 2% target, it will respond quickly. On the fiscal policy front, Congress remained deadlocked on the next round of fiscal policy measures to support the economy, leaving incremental stimulus measures to the Fed. Because global fiscal and monetary policy makers responded with record-breaking measures to “flatten the curve” and slow the spread of COVID-19, fears of an extended global recession appears to have dissipated, giving way to early concerns about “how much is too much”. The Treasury yield curve in the US, for example, steepened during the third quarter, as long-term yields increased while short-term rates declined. 

Since the bottom of the market during the COVID-19 crisis, growth stocks – particularly those associated with companies solving problems created by the pandemic – have outperformed value stocks significantly. This divergence could be a function of fears that the economy will relapse into recession and that “creative destruction” associated with innovation will plague traditional value sectors like financial services, energy, and industrials. That said, cyclical sectors could benefit as producers continue to catch up with consumer demand during this expansion. The consumer saving rate in the US has dropped from a record high of 34% during the early days of the pandemic but still is nearly twice as high as the 8% recorded in March, likely mirroring high rates in the rest of the world and suggesting that pent-up demand will support the recovery now under way. Indeed, given the record-breaking drawdown in inventories in the US during the second and third quarters, businesses seem to have been caught off guard and are scrambling to catch up with demand, suggesting a much stronger than expected V-shaped recovery during the next year.

Relative to the S&P 500 Index and the MSCI World Index, ARK’s five actively managed ETFs outperformed during the third quarter. ARK’s two self-indexed ETFs turned in mixed performance.

To read a summary of ARK’s biggest contributors and detractors, please see below.

ARK Autonomous Technology and Robotics ETF (ARKQ)

The ARK Autonomous Technology and Robotics ETF (ARKQ) outperformed the broad-based market indexes. Among the top contributors to performance was Tesla (TSLA). Tesla surpassed expectations for revenue and earnings during the second quarter, potentially setting it up for inclusion in the S&P 500 index at some point in the future. At Battery Day, Tesla presented plans not only to reduce battery costs by 56%, but also to increase range by 54% and reduce capital costs by 69%, enabling the production of an electric vehicle (EV) with a $25,000 sticker price during the next three years. In our view, Tesla is three to four years ahead of the competition in the electric vehicle space. In the absence of specific news, Materialize (MTLS) also contributed positively to performance, particularly after the COVID-19 pandemic highlighted the importance of its software in quick-turn manufacturing solutions and after Desktop Metal’s roadshow stirred investor interest in 3D printing.

Among the top detractors were Stratasys (SSYS) and 2U (TWOU). 3D printing company Stratasys disappointed second quarter revenue expectations with sales down nearly 30% on a year-over-year basis. Its new CEO, Yoav Zeif, is focusing Stratasys on plastic 3D printing and manufacturing. 2U detracted from performance even though colleges are adapting to COVID-19 by embracing remote education at an accelerated rate. During the second quarter, 2U exceeded top line expectations but missed them on the bottom line and raised roughly $300 million in a secondary equity offering.

ARK Next Generation Internet ETF (ARKW)

The ARK Next Generation Internet ETF (ARKW) outperformed the broad-based market indexes during the quarter. Among the top contributors was Tesla (TSLA) for reasons noted above. Square (SQ) also contributed as its seller businesses recovered much more quickly than expected from the COVID-19 crisis, and Cash App also delivered stronger than expected growth during the second quarter. Square pivoted its offline sellers to online commerce, increasing the latter’s gross payment volume (GPV) by 50%. Roughly one third of its online sellers were new to Square. 

Among the Next Generation Internet’s top detractors were Alteryx (AYX) and Slack Technologies (WORK). Alteryx delivered weak second quarter earnings as revenue growth dropped from 43% on a year over year basis in the first quarter to 17% in the face of flat bookings, triggering our exit. Slack Technologies detracted from performance after billings growth decelerated from 49% in the first quarter to 24% as its customers laid off users in response to the COVID-19 crisis. Slack Connect, which allows intercompany communications, saw a user growth of 200% in the quarter, enabling the company to capture new customers organically.

ARK Genomic Revolution ETF (ARKG)

The ARK Genomic Revolution ETF (ARKG) outperformed the broad-based market indexes. Among the top contributors to performance was Seres Therapeutics (MCRB). Seres Therapeutics appreciated after reporting positive top line data from its SER-109 trial which tested a microbiome therapeutic for C. difficile. Invitae (NVTA) contributed to performance after it acquired ArcherDx, a precision oncology company focused on high-quality, decentralized molecular diagnostics. We believe that once the two companies integrate, Invitae is likely to offer the most accurate, comprehensive, and flexible oncology tests in the world. Moreover, its investments in telemedicine, AI, genetic counseling, world-class germline variant interpretation, pharmacogenomics, and clinical workflows should give Invitae an advantage over the competition.

Among the top detractors were Illumina (ILMN) and Inovio Pharmaceuticals (INO). Illumina detracted from performance primarily because the company announced its intention to increase its ownership of GRAIL, an innovative cancer screening company, from 15% to 100% for $8 billion. While GRAIL’s methylation-based approach to multi-cancer screening is accurate and cost-effective, we do not believe that it has a significant technological or IP advantage over other screening companies like Guardant Health (GH), Exact Sciences (EXAS), etc. Inovio depreciated primarily because the FDA placed a clinical hold on the Phase II/III trial of its COVID-19 vaccine, INO-4800. Inovio will respond in October, at which point the agency will have 30 days to decide whether or not the trial can proceed.

ARK Fintech Innovation ETF (ARKF)

The ARK Fintech Innovation ETF (ARKF) outperformed the broad-based market indexes during the quarter. Among the top contributors were Square (SQ), for reasons noted above, and Zillow (Z). Zillow contributed to performance after a St. Louis Federal Reserve report that homeownership in the second quarter rose to levels not seen since July 2009. We believe that the residential real estate market and Zillow will continue to benefit from mortgage rates that have dropped to 50-year lows and from the premium now placed on personal space as a result of COVID-19.

Among the top detractors were Slack Technologies (WORK), for reasons noted above, and Splunk (SPLK). Splunk announced weaker than expected third quarter guidance.  Also Sumo Logi, which offers “Splunk-like” functionality in the cloud, announced that it will conduct an initial public offering. We believe that the breadth and depth of Splunk’s products are difficult to duplicate.

ARK Innovation ETF (ARKK)

With some of the highest conviction names from the Funds discussed above, the ARK Innovation ETF (ARKK) outperformed the broad-based indexes during the quarter. Among the top contributors were Tesla and Square, for reasons noted above. Detracting from performance were Illumina and Slack Technologies, for reasons noted above.

The 3D Printing ETF (PRNT)

ARK’s self-indexed ETFs, The 3D Printing ETF (PRNT) and the ARK Israel Innovation Technology ETF (IZRL), appreciated during the quarter, with mixed performance. The 3D Printing ETF (PRNT) outperformed relative to the broad-based market indexes. Materialize (MTLS) was the largest contributor in PRNT, for reasons noted above. 3D Systems (DDD) was the largest detractor from performance after it missed analysts’ estimates for the second quarter and announced a restructuring focused on Healthcare and Industrial, spearheaded by new CEO, Jeffrey Graves. 3D Systems also appointed Jagtar Narula as CFO, who brings experience from Blackbaud, Xerox, and GE.

ARK Israel Innovation Technology ETF (IZRL)

The ARK Israel Innovation Technology ETF (IZRL) under-performed the broad-based market indexes for the period. The largest detractor was Urogen Pharma (URGN), as its Phase 2 trial missed its primary endpoint of improving overactive bladder symptoms. IZRL’s top contributor to performance was Fiverr International (FVRR), the marketplace for freelance services, which benefited from the shift to online commerce in the face of the COVID-19 crisis.

ARK’s statements are not an endorsement of any company or a recommendation to buy, sell or hold any security. ARK and its clients as well as its related persons may (but do not necessarily) have financial interests in securities or issuers that are discussed. Certain of the statements contained may be statements of future expectations and other forward-looking statements that are based on ARK’s current views and assumptions and involve known and unknown risks and uncertainties that could cause actual results, performance, or events to differ materially from those expressed or implied in such statements.

Explore ARK Funds

Featured Funds:

ARKQ Icon

ARK Autonomous Tech. & Robotics ETF

ARKW Icon

ARK Next Generation Internet ETF

ARKG Icon

ARK Genomic Revolution ETF

ARKK Icon

ARK Innovation ETF

PRNT Icon

The 3D Printing ETF

IZRL Icon

ARK Israel Innovative Technology ETF

ARKF Icon

ARK Fintech Innovation ETF

ARKX Icon

ARK Space Exploration & Innovation ETF

See All

ARK Trade Notifications

ARK offers fully transparent Exchange Traded Funds (“ETFs”) and provides investors with trade information for all actively managed ETFs.